Celling Biosciences Competitors and Similar CompaniesClear all

Orthocell's competitors and similar companies include Celldex Therapeutics.
Orthocell
Orthocell
Orthocell is a company that develops devices for regenerating mobility of tendon, cartilage, and soft tissue.
Celldex Therapeutics
Celldex Therapeutics
Celldex Therapeutics (formerly Avant Immunotherapeutics) is a biopharmaceutical company that specializes in monoclonal and bispecific antibodies development.
Founding Date
Founding Date
2006
Founding Date
1983
Type
Type
Public
Type
Public
Tags
Locations
Locations
Murdoch, AU HQ
Locations
Hampton, US HQ
Fall River, US
Needham, US
New Haven, US
Employees
Employees
N/A
Employees
1608% increase
Valuation ($)
Valuation ($)
65.5 m
Valuation ($)
1.9 b

Financial

Revenue (est.)
Revenue (est.)
$7.6m (FY, 2025)
Revenue (est.)
$1.5m (FY, 2025)
Cost of goods
Cost of goods
$2.2m (FY, 2025)
Cost of goods
$200k (FY, 2025)
Gross profit
Gross profit
$5.7m (FY, 2025)
Gross profit
$1.3m (FY, 2025)
Net income
Net income
($8.6m) (FY, 2025)
Net income
($258.8m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Celldex Therapeutics
HQ
Hampton, US
Employees
160↑ 8% increase

Celldex Therapeutics (formerly Avant Immunotherapeutics) is a biopharmaceutical company that specializes in monoclonal and bispecific antibodies development.

View company